MRNA dropped 6.8% on November 10 to $250.83, giving back a slice of the 11.4% earnings gap that followed its Q3 print four days earlier, while closest peer BNTX fell less than half a percent on the same session and CRSP tumbled nearly 10%. The contrast matters: Moderna's week still ended up 9.8% against a median decline of roughly 3.2% across its…
MRNA short interest climbed 23% over the past week to 9.05% of float, driven by heavy accumulation since early October. Availability remains abundant at 478%, signaling easy shorting conditions despite the rally.
Key data as of 12 Nov 2026
MRNA short interest climbed 23% over the past week to 9.05% of float, driven by heavy accumulation since early October. Availability remains abundant at 478%, signaling easy shorting conditions despite the rally.
5 Short Interest updates in 30 days
A Citigroup downgrade to Sell lands just as short sellers accelerate their exit from MRNA, creating an unusual split signal: one major bank is turning bearish on a stock that the shorts who know it best are quietly…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRNA — free to start on ORTEX.
Sign up for free →Open MRNA on ORTEX